Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.1B | 3.2B | 2.9B | 3.1B |
| Cost of revenue | 2.7B | 2.9B | 2.6B | 2.8B |
| Gross profit | 353M | 313M | 295M | 363M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 243M | 270M | 221M | 238M |
| Other operating expenses | — | — | — | — |
| Operating income | 110M | 43M | 74M | 125M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 70M | 0 | 26M | 86M |
| Tax provision | 20M | 12M | 10M | 24M |
| Net income | 50M | -13M | 17M | 62M |
| Basic EPS | 0.5 | -0.1 | 0.2 | 0.7 |
| Diluted EPS | 0.5 | -0.1 | 0.2 | 0.7 |
| Basic average shares | 1.0B | 1.0B | 1.0B | 1.0B |
| Diluted average shares | 1.0B | 1.0B | 1.0B | 1.0B |
| EBITDA | 110M | 43M | 74M | 125M |
| Net income from continuing op. | 110M | 43M | 73M | 125M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |